With 17 votes to 4 and 1 abstention, the U.S. Food and Drug Administration (FDA) Advisory Committee voted on the 10th to recommend that the federal government approve emergency access to the Pfizer vaccine. Although the FDA may not necessarily do so, but according to the practice, the FDA usually accepts the recommendation, the U.S. media reported that the fastest Friday (11), the FDA can formally authorize consent to the emergency use of Pfizer vaccine, and the initial may be 16 years old as the boundary, young children, pregnant women will not be in the scope of the object can be administered.
The vaccine has been developed by the U.S. pharmaceutical company Pfizer and the German biotechnology company BioNTech. The vaccine has already been launched in the United Kingdom, and even the 94-year-old Queen and her son-in-law are willing to administer it.
The U.S. side appears to be more cautious, and the FDA advisory committee on the 10th day, on a question into: “Based on current scientific evidence, is the benefit of the Pfizer vaccine for individuals 16 years old or older more than the risk”? Finally, the committee members voted 17 to 4, with one abstention, to approve the recommendation. The vote will be followed by a review by the FDA’s Center for Biologics Evaluation and Research (CBER) before a final decision is made.
CNBC reported that FDA committee member James Hildreth said in an interview earlier that the FDA could authorize emergency use of Pfizer vaccines as early as Friday, and that emergency use authorizations typically allow the drug or vaccine to be administered to a limited number of people or sites, such as hospitalized patients.
The report said it was unclear who the FDA would authorize for emergency use, except that the committee recommended emergency approval of the vaccine for people 16 years of age and older, but pregnant women and young children may not be covered by the emergency authorization.
Recent Comments